Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM
Ontology highlight
ABSTRACT: To date no prospective trials have been completed that demonstrated whether RFA is an effective adjunct to systemic chemotherapy (target therapy) with respect to advantages in overall survival compared with chemotherapy (target therapy) alone. The primary objective of this trial is to determine overall survival for patients with colorectal cancer liver metastasis are treated with radiofrequency ablation plus chemotherapy ± target therapy, compared to chemotherapy ± target therapy only.
DISEASE(S): Neoplasm Metastasis,Colorectal Cancer,Colorectal Neoplasms,Colorectal Cancer Liver Metastasis,Liver Neoplasms
PROVIDER: 2242376 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA